Global Patterns of Incidence and Mortality in Lung Cancer
Objectives: Lung cancer has been the leading cause of cancer mortality, and its incidence is growing throughout the world. This study aims to compare the distribution of the six World Health Organization by configural frequency analysis (CFA). Methods: The National data (GLOBOCAN 2012) were included in the analysis. Data were analyzed by CFA which is used for the analysis of multiway contingency tables. Results: In Africa, East Mediterranean, Europe, and Southeast Asia, lung cancer incident cases were observed to be higher than expected. Under the years <70, in Africa, East Mediterranean, Europe, and Southeast Asia, lung cancer mortality is significantly underrepresented and therefore antitypes. Here, lung cancer mortality was observed lower than expected. In the more developed regions, lung cancer incident cases and mortality were significantly overrepresented in almost all age groups in both male (years <55) and female, but in the less developed regions, it was significantly underrepresented in almost all age groups. Conclusion: The majority of the global lung cancer burden occurred in the more developed countries. If the current situation remains unchanged, incidence and mortality may continue to increase.
1. Brown WR, Ahnen DJ. The international health care burden of cancers of the gastrointestinal tract and liver. Cancer Res Front 2014;1:1–9.
2. Stewart BW, Wild CP, editors. World Cancer Report. Lyon, France: International Agency for Research on Cancer; 2014.
3. American Cancer Society. Global Cancer Facts and Figures. 3rd ed. Atlanta: American Cancer Society; 2015.
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D, et al. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
5. Youlden DR, Cramb SM, Baade PD. The international epidemiology of lung cancer: Geographical distribution and secular trends. J Thorac Oncol 2008;3:819–31. [CrossRef]
6. GLOBOCAN 2012. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Available at: http://www. globocan.iarc.fr/Default.aspx.
7. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 1. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http:// www.globocan.iarc.fr.
8. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 2013;132:1133–45. [CrossRef]
9. World Health Organization (WHO). Health Statistics and İnformation Systems, Definition of Region Groupings. Available at: http://www.who.int/healthinfo/global_burden_disease/definition_regions/en. Accessed Dec 20, 2018.
10. Lars R. Bergmana1, Wångby M. The person-oriented approach: A short theoretical and practical guide. Eesti Haridusteaduste Ajakiri 2014;2:29–49. [CrossRef]
11. von Eye A. Introduction to Configural Frequency Analysis. Canada: Cambridge University Press; 1990. p. 3–39. [CrossRef]
12. von Eye A. The odds favor antitypes: A comparison of tests for the identification of configural types and antitypes. Methods Psychol Res 2002;7:1–29.
13. von Eye A, Pena EG. Configural frequency analysis of large sparse cross-classifications. Psychol Sci 2005;47:356–76.
14. Stemmler M. Person-Centered Methods: CFA and Other Methods for The Analysis of Contingency Tables. Switzerland: Springer International Publishing; 2014. p. 19–23. [CrossRef]
15. Holm, S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65–70.
16. ArcGIS 10.3 for Desktop, Esri İnc. Available at: http://www.esri. com.
17. American Cancer Society. Cancer in Africa. Atlanta; 2011.
18. Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res 2015;4:327–38.
19. Martiniuk A, Lee CM, Woodward M, Huxley R. Burden of lung cancer deaths due to smoking for men and women in the WHO western pacific and South East Asian regions. Asian Pac J Cancer Prev 2010;11:67–72.
20. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, et al. Annual report to the nation on the status of cancer, 1975- 2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008;100:1672–94. [CrossRef]
21. Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: Epidemiology, etiology, and prevention. Clin Chest Med 2011;32:605–44.
22. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7–30. [CrossRef]
23. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108.
24. Didkowska J, Wojciechowska U, Mańczuk M, Łobaszewski J. Lung cancer epidemiology: Contemporary and future challenges worldwide. Ann Transl Med 2016;4:150. [CrossRef]
25. Bosetti C, Malvezzi M, Rosso T, Bertuccio P, Gallus S, Chatenoud L, et al. Lung cancer mortality in European women: Trends and predictions. Lung Cancer 2012;78:171–8. [CrossRef]